Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation: Multicenter Randomized Clinical Trial

NCT05283356 is registered in ClinicalTrials.gov with Fundacin Biomedica Galicia Sur as lead sponsor.

NCT NCT05283356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05283356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation: Multicenter Randomized Clinical Trial
Lead sponsor
Fundacin Biomedica Galicia Sur
Phase
Phase 4
Overall status
Recruiting
Start date
January 21, 2022
Completion date
June 30, 2028
Enrollment
1,206 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, severe aortic valve stenosis, transcatheter aortic valve implantation (tavi), transcatheter aortic valve replacement (tavr)